These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Constant-flow drug administration in anesthesia]. Richard JP; Bareille P; Pujol MP; Conil JM; Antonini A Cah Anesthesiol; 1988 Sep; 36(5):365-6. PubMed ID: 2903791 [TBL] [Abstract][Full Text] [Related]
3. Special aspects of pharmacokinetics of inhalation anesthesia. Hendrickx JF; De Wolf A Handb Exp Pharmacol; 2008; (182):159-86. PubMed ID: 18175091 [TBL] [Abstract][Full Text] [Related]
4. Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone. Wagner JG; DiSanto AR; Gillespie WR; Albert KS Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):387-405. PubMed ID: 7268190 [TBL] [Abstract][Full Text] [Related]
5. Quantitative evaluation of dichloroacetic acid kinetics in human--a physiologically based pharmacokinetic modeling investigation. Li T; Schultz I; Keys DA; Campbell JL; Fisher JW Toxicology; 2008 Mar; 245(1-2):35-48. PubMed ID: 18242812 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of aztreonam administered by continuous intravenous infusion. Burgess DS; Summers KK; Hardin TC Clin Ther; 1999 Nov; 21(11):1882-9. PubMed ID: 10890260 [TBL] [Abstract][Full Text] [Related]
7. [Anesthesia and continuous flow]. Duvelleroy MA Anesth Analg (Paris); 1977; 34(6):1143-53. PubMed ID: 613874 [No Abstract] [Full Text] [Related]
9. Optimal intravenous dosing strategies for sedatives and analgesics in the intensive care unit. Barr J; Donner A Crit Care Clin; 1995 Oct; 11(4):827-47. PubMed ID: 8535981 [TBL] [Abstract][Full Text] [Related]
10. The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part III. Propranolol. Orszulak-Michalak D Acta Pol Pharm; 1995; 52(4):309-13. PubMed ID: 8960259 [TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan at clinical and supraclinical doses. Whittem T; Pasloske KS; Heit MC; Ranasinghe MG J Vet Pharmacol Ther; 2008 Dec; 31(6):571-9. PubMed ID: 19000281 [TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of isosorbide dinitrate administered by intravenous infusion to hypertensive patients (author's transl)]. Frydman A; Levenson J; Simon A; Safar M; Bieder A; Bertharion J; Gaillot J Nouv Presse Med; 1982 Jun; 11(27):2049-56. PubMed ID: 7110964 [TBL] [Abstract][Full Text] [Related]
13. [Effect of duration of infusion on elimination rate of alfentanil]. Castor G; Altmayer P; Venitz J Anaesthesiol Reanim; 1995; 20(4):97-100. PubMed ID: 7575958 [TBL] [Abstract][Full Text] [Related]
14. The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part IV. Lidocaine. Orszulak-Michalak D Acta Pol Pharm; 1995; 52(4):315-9. PubMed ID: 8960260 [TBL] [Abstract][Full Text] [Related]
15. The effect of hydroxyethylstarch infusion on bupivacaine pharmacokinetics in rats. Okutomi T; Matsumoto Y; Saito M; Shimizu M; Hoka S; Kuczkowski KM Acta Anaesthesiol Belg; 2006; 57(3):259-64. PubMed ID: 17067137 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic studies of anticancer drugs in tumor-bearing animals. Donelli MG; D'Incalci M; Garattini S Cancer Treat Rep; 1984 Feb; 68(2):381-400. PubMed ID: 6697328 [TBL] [Abstract][Full Text] [Related]
17. [Characteristics of drugs necessitating a continuous parenteral flow]. Dixneuf B Anesth Analg (Paris); 1977; 34(6):1121-5. PubMed ID: 26295 [No Abstract] [Full Text] [Related]
18. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model. Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of recombinant human interleukin 3 administered subcutaneously and by continuous intravenous infusion in patients after chemotherapy for ovarian cancer. Biesma B; Pokorny R; Kovarik JM; Duffy FA; Willemse PH; Mulder NH; de Vries EG Cancer Res; 1993 Dec; 53(24):5915-9. PubMed ID: 8261403 [TBL] [Abstract][Full Text] [Related]